PICK A TIME SLOT
₹ Price not available
Goa
₹
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
We have sent you an OTP on
Resend OTP
Did not receive OTP? You can request for another OTP. Click on Resend OTP
Go Back
Your appointment is
confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Dr. Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr. Nakul is known for his patient-focused approach and commitment to evidence-based care.
Dr. Nakul completed his super-speciality training (DM) in Clinical Haematology from the prestigious AIIMS, Bhubaneswar. His earlier qualifications include an MD in Internal Medicine and an MBBS from Goa Medical College, Bambolim. Over the years, he has gained hands-on experience from top institutions such as SGPGI Lucknow and Rajiv Gandhi Cancer Institute, New Delhi.
Dr. Nakul’s areas of interest include bone marrow transplant (BMT), cellular therapy, Immunohaematology, and Haematologic cancers such as leukaemia, lymphoma, and multiple myeloma. He has also worked extensively on chronic myeloid leukaemia (CML) and disorders of thrombocytopenia.
He has contributed to several national and international publications, with research featured in leading journals like Clinical Lymphoma Myeloma Leukaemia, BMJ Case Reports, and Blood Journal.
Dr. Nakul actively participates in medical conferences and MHG webinars. He is committed to continuous learning and regularly participates in academic discussions and clinical research. At Manipal Hospitals, Goa, he brings a strong combination of clinical knowledge, research experience, and compassionate care to treat complex blood-related disorders and improve patient outcomes.
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
- English
- Hindi
- Konkani
- Marathi
- Presenter at multiple national-level conferences such as MHG Annual Conferences (2016, 2019, 2023, 2024), Best of ASH 2020
- Dr Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr Tikare is known for his patient-focused approach and commitment to evidence-based care.
- Selected to present multiple papers in the Blood journal (ASH abstracts), highlighting research in Hairy Cell Leukaemia, FLT3 mutated AML, and Dasatinib strategies
- Tikare N et al. Efficacy of low-dose dasatinib (50mg) in chronic myeloid leukaemia: Chronic phase (CML-CP) in LMIC—Are we there yet?. Journal of Clinical Oncology 2025
- Pritish P, Sujay R, Tikare N et al. Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India. Annals of Hematology 2025
- Panigrahi C, Tikare N, et al. Core-binding factor abnormalities involving chromosome 16 in AML. BMJ Case Reports 2023.
- Sonali M, et al. Pediatric systemic mastocytosis with clonal non-mast cell neoplasm. Am J Leuk Res 2023.
- Soni A, Tikare N, et al. Real-world outcome of high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 2024.
- Panda T, Tikare N, et al. Rituximab + Cladirabine in Hairy Cell Leukaemia. Blood Journal 2024.
- Singh R, Tikare N, et al. Dasatinib de-escalation in CML. Blood Journal 2024.
- Disha D, Tikare N, et al. Gilteritinib in FLT3-mutated r/r AML. Blood Journal 2024.
- Poster at MHG Annual Conference 2023 – Dasatinib adverse events mimicking ulcerative colitis.
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
- English
- Hindi
- Konkani
- Marathi
Dr. Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr. Nakul is known for his patient-focused approach and commitment to evidence-based care.
Dr. Nakul completed his super-speciality training (DM) in Clinical Haematology from the prestigious AIIMS, Bhubaneswar. His earlier qualifications include an MD in Internal Medicine and an MBBS from Goa Medical College, Bambolim. Over the years, he has gained hands-on experience from top institutions such as SGPGI Lucknow and Rajiv Gandhi Cancer Institute, New Delhi.
Dr. Nakul’s areas of interest include bone marrow transplant (BMT), cellular therapy, Immunohaematology, and Haematologic cancers such as leukaemia, lymphoma, and multiple myeloma. He has also worked extensively on chronic myeloid leukaemia (CML) and disorders of thrombocytopenia.
He has contributed to several national and international publications, with research featured in leading journals like Clinical Lymphoma Myeloma Leukaemia, BMJ Case Reports, and Blood Journal.
Dr. Nakul actively participates in medical conferences and MHG webinars. He is committed to continuous learning and regularly participates in academic discussions and clinical research. At Manipal Hospitals, Goa, he brings a strong combination of clinical knowledge, research experience, and compassionate care to treat complex blood-related disorders and improve patient outcomes.
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
- Presenter at multiple national-level conferences such as MHG Annual Conferences (2016, 2019, 2023, 2024), Best of ASH 2020
- Dr Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr Tikare is known for his patient-focused approach and commitment to evidence-based care.
- Selected to present multiple papers in the Blood journal (ASH abstracts), highlighting research in Hairy Cell Leukaemia, FLT3 mutated AML, and Dasatinib strategies
- Tikare N et al. Efficacy of low-dose dasatinib (50mg) in chronic myeloid leukaemia: Chronic phase (CML-CP) in LMIC—Are we there yet?. Journal of Clinical Oncology 2025
- Pritish P, Sujay R, Tikare N et al. Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India. Annals of Hematology 2025
- Panigrahi C, Tikare N, et al. Core-binding factor abnormalities involving chromosome 16 in AML. BMJ Case Reports 2023.
- Sonali M, et al. Pediatric systemic mastocytosis with clonal non-mast cell neoplasm. Am J Leuk Res 2023.
- Soni A, Tikare N, et al. Real-world outcome of high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 2024.
- Panda T, Tikare N, et al. Rituximab + Cladirabine in Hairy Cell Leukaemia. Blood Journal 2024.
- Singh R, Tikare N, et al. Dasatinib de-escalation in CML. Blood Journal 2024.
- Disha D, Tikare N, et al. Gilteritinib in FLT3-mutated r/r AML. Blood Journal 2024.
- Poster at MHG Annual Conference 2023 – Dasatinib adverse events mimicking ulcerative colitis.
Languages Spoken
Overview
Field of Expertise
Awards & Achievements
Talks & Publications
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
- English
- Hindi
- Konkani
- Marathi
- Presenter at multiple national-level conferences such as MHG Annual Conferences (2016, 2019, 2023, 2024), Best of ASH 2020
- Dr Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr Tikare is known for his patient-focused approach and commitment to evidence-based care.
- Selected to present multiple papers in the Blood journal (ASH abstracts), highlighting research in Hairy Cell Leukaemia, FLT3 mutated AML, and Dasatinib strategies
- Tikare N et al. Efficacy of low-dose dasatinib (50mg) in chronic myeloid leukaemia: Chronic phase (CML-CP) in LMIC—Are we there yet?. Journal of Clinical Oncology 2025
- Pritish P, Sujay R, Tikare N et al. Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India. Annals of Hematology 2025
- Panigrahi C, Tikare N, et al. Core-binding factor abnormalities involving chromosome 16 in AML. BMJ Case Reports 2023.
- Sonali M, et al. Pediatric systemic mastocytosis with clonal non-mast cell neoplasm. Am J Leuk Res 2023.
- Soni A, Tikare N, et al. Real-world outcome of high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 2024.
- Panda T, Tikare N, et al. Rituximab + Cladirabine in Hairy Cell Leukaemia. Blood Journal 2024.
- Singh R, Tikare N, et al. Dasatinib de-escalation in CML. Blood Journal 2024.
- Disha D, Tikare N, et al. Gilteritinib in FLT3-mutated r/r AML. Blood Journal 2024.
- Poster at MHG Annual Conference 2023 – Dasatinib adverse events mimicking ulcerative colitis.
Dr. Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr. Nakul is known for his patient-focused approach and commitment to evidence-based care.
Dr. Nakul completed his super-speciality training (DM) in Clinical Haematology from the prestigious AIIMS, Bhubaneswar. His earlier qualifications include an MD in Internal Medicine and an MBBS from Goa Medical College, Bambolim. Over the years, he has gained hands-on experience from top institutions such as SGPGI Lucknow and Rajiv Gandhi Cancer Institute, New Delhi.
Dr. Nakul’s areas of interest include bone marrow transplant (BMT), cellular therapy, Immunohaematology, and Haematologic cancers such as leukaemia, lymphoma, and multiple myeloma. He has also worked extensively on chronic myeloid leukaemia (CML) and disorders of thrombocytopenia.
He has contributed to several national and international publications, with research featured in leading journals like Clinical Lymphoma Myeloma Leukaemia, BMJ Case Reports, and Blood Journal.
Dr. Nakul actively participates in medical conferences and MHG webinars. He is committed to continuous learning and regularly participates in academic discussions and clinical research. At Manipal Hospitals, Goa, he brings a strong combination of clinical knowledge, research experience, and compassionate care to treat complex blood-related disorders and improve patient outcomes.
Field of Expertise
Languages Spoken
Awards & Achievements
Talks & Publications
Overview
- Presenter at multiple national-level conferences such as MHG Annual Conferences (2016, 2019, 2023, 2024), Best of ASH 2020
- Dr Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr Tikare is known for his patient-focused approach and commitment to evidence-based care.
- Selected to present multiple papers in the Blood journal (ASH abstracts), highlighting research in Hairy Cell Leukaemia, FLT3 mutated AML, and Dasatinib strategies
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
- English
- Hindi
- Konkani
- Marathi
- Tikare N et al. Efficacy of low-dose dasatinib (50mg) in chronic myeloid leukaemia: Chronic phase (CML-CP) in LMIC—Are we there yet?. Journal of Clinical Oncology 2025
- Pritish P, Sujay R, Tikare N et al. Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India. Annals of Hematology 2025
- Panigrahi C, Tikare N, et al. Core-binding factor abnormalities involving chromosome 16 in AML. BMJ Case Reports 2023.
- Sonali M, et al. Pediatric systemic mastocytosis with clonal non-mast cell neoplasm. Am J Leuk Res 2023.
- Soni A, Tikare N, et al. Real-world outcome of high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 2024.
- Panda T, Tikare N, et al. Rituximab + Cladirabine in Hairy Cell Leukaemia. Blood Journal 2024.
- Singh R, Tikare N, et al. Dasatinib de-escalation in CML. Blood Journal 2024.
- Disha D, Tikare N, et al. Gilteritinib in FLT3-mutated r/r AML. Blood Journal 2024.
- Poster at MHG Annual Conference 2023 – Dasatinib adverse events mimicking ulcerative colitis.
Dr. Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr. Nakul is known for his patient-focused approach and commitment to evidence-based care.
Dr. Nakul completed his super-speciality training (DM) in Clinical Haematology from the prestigious AIIMS, Bhubaneswar. His earlier qualifications include an MD in Internal Medicine and an MBBS from Goa Medical College, Bambolim. Over the years, he has gained hands-on experience from top institutions such as SGPGI Lucknow and Rajiv Gandhi Cancer Institute, New Delhi.
Dr. Nakul’s areas of interest include bone marrow transplant (BMT), cellular therapy, Immunohaematology, and Haematologic cancers such as leukaemia, lymphoma, and multiple myeloma. He has also worked extensively on chronic myeloid leukaemia (CML) and disorders of thrombocytopenia.
He has contributed to several national and international publications, with research featured in leading journals like Clinical Lymphoma Myeloma Leukaemia, BMJ Case Reports, and Blood Journal.
Dr. Nakul actively participates in medical conferences and MHG webinars. He is committed to continuous learning and regularly participates in academic discussions and clinical research. At Manipal Hospitals, Goa, he brings a strong combination of clinical knowledge, research experience, and compassionate care to treat complex blood-related disorders and improve patient outcomes.
Awards & Achievements
Field of Expertise
Languages Spoken
Talks & Publications
Overview
- Tikare N et al. Efficacy of low-dose dasatinib (50mg) in chronic myeloid leukaemia: Chronic phase (CML-CP) in LMIC—Are we there yet?. Journal of Clinical Oncology 2025
- Pritish P, Sujay R, Tikare N et al. Allogeneic transplantation for CML blast phase: Learnings over last decade from a single centre in North India. Annals of Hematology 2025
- Panigrahi C, Tikare N, et al. Core-binding factor abnormalities involving chromosome 16 in AML. BMJ Case Reports 2023.
- Sonali M, et al. Pediatric systemic mastocytosis with clonal non-mast cell neoplasm. Am J Leuk Res 2023.
- Soni A, Tikare N, et al. Real-world outcome of high-risk multiple myeloma. Clin Lymphoma Myeloma Leuk 2024.
- Panda T, Tikare N, et al. Rituximab + Cladirabine in Hairy Cell Leukaemia. Blood Journal 2024.
- Singh R, Tikare N, et al. Dasatinib de-escalation in CML. Blood Journal 2024.
- Disha D, Tikare N, et al. Gilteritinib in FLT3-mutated r/r AML. Blood Journal 2024.
- Poster at MHG Annual Conference 2023 – Dasatinib adverse events mimicking ulcerative colitis.
Dr. Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr. Nakul is known for his patient-focused approach and commitment to evidence-based care.
Dr. Nakul completed his super-speciality training (DM) in Clinical Haematology from the prestigious AIIMS, Bhubaneswar. His earlier qualifications include an MD in Internal Medicine and an MBBS from Goa Medical College, Bambolim. Over the years, he has gained hands-on experience from top institutions such as SGPGI Lucknow and Rajiv Gandhi Cancer Institute, New Delhi.
Dr. Nakul’s areas of interest include bone marrow transplant (BMT), cellular therapy, Immunohaematology, and Haematologic cancers such as leukaemia, lymphoma, and multiple myeloma. He has also worked extensively on chronic myeloid leukaemia (CML) and disorders of thrombocytopenia.
He has contributed to several national and international publications, with research featured in leading journals like Clinical Lymphoma Myeloma Leukaemia, BMJ Case Reports, and Blood Journal.
Dr. Nakul actively participates in medical conferences and MHG webinars. He is committed to continuous learning and regularly participates in academic discussions and clinical research. At Manipal Hospitals, Goa, he brings a strong combination of clinical knowledge, research experience, and compassionate care to treat complex blood-related disorders and improve patient outcomes.
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
- English
- Hindi
- Konkani
- Marathi
- Presenter at multiple national-level conferences such as MHG Annual Conferences (2016, 2019, 2023, 2024), Best of ASH 2020
- Dr Nakul Dilip Tikare is a skilled haematologist with deep expertise in managing blood-related disorders and bone marrow conditions. He is currently working as an Associate Consultant in the Department of Clinical Haematology at Manipal Hospitals, Goa. With over a decade of experience in Internal Medicine and advanced training in Clinical Haematology, Dr Tikare is known for his patient-focused approach and commitment to evidence-based care.
- Selected to present multiple papers in the Blood journal (ASH abstracts), highlighting research in Hairy Cell Leukaemia, FLT3 mutated AML, and Dasatinib strategies
Talks & Publications
Overview
Field of Expertise
Languages Spoken
Awards & Achievements
FAQ's
Patients visit Dr. Nakul Dilip Tikare, a leading Associate Consultant - Clinical Haematology at Manipal Hospitals Goa, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Nakul Dilip Tikare is a trusted choice for exceptional medical support.
Dr. Nakul Dilip Tikare Specialises in:
- Anaemia and Haemoglobin Disorders
- Bone Marrow Transplant (BMT) & Cellular Therapy, including CAR-T
- Immunohaematology
- Haemato-oncology (Leukaemia, Lymphoma, Multiple Myeloma)
- Disorders of Platelets – including ITP
- Chronic Myeloid Leukaemia (CML)
- Bleeding disorders, including Haemophilia
- Thalassemia
- Myelodysplastic Syndrome (MDS)
- Treatment of Thrombotic Disorders
- Hematologic Complications of Pregnancy
To book an appointment with Dr. Nakul Dilip Tikare at Manipal Hospitals Goa, please call 1800 102 5555. Our dedicated team will assist you in scheduling a convenient time for your consultation.
Dr. Nakul Dilip Tikare has extensive experience and qualifications in Hematology at Manipal Hospitals Goa. With expertise spanning MBBS . MD in Internal Medicine . DM in Clinical Haematology, bringing a wealth of knowledge and skill to their practice, ensuring top-notch patient care. Dr. Nakul Dilip Tikare has also published numerous articles and publications in the field of Hematology.
For your initial appointment with Dr. Nakul Dilip Tikare, please bring any relevant medical records, including previous imaging scans, laboratory results, and medication lists. It's important to provide a detailed medical history and any pertinent information about your condition. If you have insurance, please bring your insurance card and any necessary referral documents. This will help facilitate a comprehensive evaluation and discussion during your appointment.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
- Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
- In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
- Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
- A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
- I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
- I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
- The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
- There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
- Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
- Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
- I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
- I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
- I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.
